Protein may predict cancer metastasis

The presence of high levels of a particular protein in tumors drives metastasis, providing a valuable biomarker for predicting the spread of cancer.

Mechanisms governing metastasis—a major cause of mortality in cancer patients—remain elusive, noted Y. Peng Loh of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and fellow researchers in their online report of their protein discovery (The Journal of Clinical Investigation, www.jci.org/articles/view/40433/pdf). However, the team helped shed light on this process by finding that the carboxypeptidase E gene is alternatively spliced in human tumors to yield an N-terminal truncated protein that drives metastasis. Evidence of this process was seen in human metastatic colon, breast, liver, and head and neck cancer cell lines.

By measuring the protein's genetic material in human tumors and the genetic material from surrounding tissue, the investigators could predict at least 90% of the time whether a cancer would spread within 2 years, regardless of cancer stage. They call for more studies to explore this “potentially powerful biomarker for predicting future metastasis and recurrence.”

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs